(Reuters) – Reckitt Benckiser said on Friday it will sell its E45 skincare brand and related sub-brands to Karo Pharma for 200 million pounds ($267.98 million), as the British consumer goods maker shifts its focus to higher growth areas.
The Durex condom and Lysol disinfectant maker said the businesses generated a combined net revenue of 43 million pounds last year.
($1 = 0.7463 pounds)
(Reporting by Siddharth Cavale in Bengaluru; editing by Uttaresh.V)
